搜索医生

Chenchen Qian, M.D.

  1. Internist

出版物

  1. Ran L, Chen M, Ye J, Zhang S, Luo Z, Bai T, Qian C, Zhou Q, Shan M, Chu Y, Herrmann J, Li Q, Wang F. UK5099 Inhibits the NLRP3 Inflammasome Independently of its Long-Established Target Mitochondrial Pyruvate Carrier. Adv Sci (Weinh). 2024 Sep; 11 (33):e2307224 Epub 2024 July 01
    View PubMed
  2. Lin SN, Mao R, Qian C, Bettenworth D, Wang J, Li J, Bruining DH, Jairath V, Feagan BG, Chen MH, Rieder F, Stenosis Therapy and Antifibrotic Research (STAR) Consortium. Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases. Physiol Rev. 2022 Apr 1; 102 (2):605-652 Epub 2021 Sept 27
    View PubMed
  3. Hua J, Zhang X, Wang N, Ran L, Wang S, Huang C, Gao W, Qian C, Guo W, Liu Z, Li Q, Wang F. Extracorporeal Membrane Oxygenation for COVID-19: Case Report of Nine Patients. Front Med (Lausanne). 2021; 8:697338 Epub 2021 Nov 12
    View PubMed
  4. Qian C, Abourizk N, Rizk MA, Kim J, Smith DL, Westra KC, McLaughlin JP. A rare case of metronidazole induced recurrent pancreatitis. Pancreatology 2021 Jan; 21 (1):318-319 Epub 2020 Nov 05
    View PubMed
  5. Hansrivijit P, Qian C, Boonpheng B, Thongprayoon C, Vallabhajosyula S, Cheungpasitporn W, Ghahramani N. Incidence of acute kidney injury and its association with mortality in patients with COVID-19: a meta-analysis. J Investig Med. 2020 Oct; 68 (7):1261-1270 Epub 2020 July 12
    View PubMed
  6. Hua J, Qian C, Luo Z, Li Q, Wang F. Invasive mechanical ventilation in COVID-19 patient management: the experience with 469 patients in Wuhan. Crit Care 2020 Jun 16; 24 (1):348 Epub 2020 June 16
    View PubMed
  7. Wang F, Ran L, Qian C, et al. Epidemiology and outcomes of acute kidney injury in COVID-19 patients with acute respiratory distress syndrome: a multicenter retrospective study. Blood Purification. 2020.
  8. Su M, Qian C, Hu Y, Lu W, Huang R, Chen M, Chen J. Inhibitory effect of the low-toxic exogenous aryl hydrocarbon receptor modulator 3'3-diindolylmethane on gastric cancer in mice. Oncol Lett. 2017 Dec; 14 (6):8100-8105 Epub 2017 Oct 16
    View PubMed
  9. Zhang QB, Chen SJ, Zeng LI, Chen YT, Lian GD, Qian CC, Li JJ, Xie RJ. New developments in the early diagnosis of pancreatic cancer. Expert review of gastroenterology & hepatology. 2017; 11(2):149-56.
  10. Dai J, Qian C, Su M, Chen M, Chen J. Gastrokine-2 suppresses epithelial mesenchymal transition through PI3K/AKT/GSK3beta signaling in gastric cancer. Tumour Biol. 2016 Sep; 37 (9):12403-12410 Epub 2016 June 21
    View PubMed
  11. Pan CW, Liu H, Zhao Y, Qian C, Wang L, Qi J. JNK2 downregulation promotes tumorigenesis and chemoresistance by decreasing p53 stability in bladder cancer. Oncotarget. 2016 Jun 7; 7 (23):35119-31
    View PubMed
  12. Zhang Q, Zeng L, Chen Y, Lian G, Qian C, Chen S, Li J, Huang K. Pancreatic cancer epidemiology, detection, and management. Gastroenterology research and practice. 2016.
  13. Zeng L, Li J, Li J, Zhang Q, Qian C, Wu W, Lin Z, Liang J, Chen Y, Huang K. Effective suppression of the Kirsten rat sarcoma viral oncogene in pancreatic tumor cells via targeted small interfering RNA delivery using nanoparticles. Pancreas. 2015 Mar; 44 (2):250-9
    View PubMed
  14. Chen SJ, Zhang QB, Zeng LJ, Lian GD, Li JJ, Qian CC, Chen YZ, Chen YT, Huang KH. Distribution and clinical significance of tumour-associated macrophages in pancreatic ductal adenocarcinoma: a retrospective analysis in China. Current Oncology. 2015; 22(1).
  15. Zeng L, Li J, Wang Y, Qian C, Chen Y, Zhang Q, Wu W, Lin Z, Liang J, Shuai X, Huang K. Combination of siRNA-directed Kras oncogene silencing and arsenic-induced apoptosis using a nanomedicine strategy for the effective treatment of pancreatic cancer. Nanomedicine. 2014 Feb; 10 (2):463-72 Epub 2013 Sept 09
    View PubMed
  16. Zeng L, Jingguo LI, Zhang Q, Qian C, LIn Z, Chen Y, Huang K. Establishment of human pancreatic tumor xenograft mouse model for evaluating tumor-homing and gene- silencing effects of siRNA-loading nanoparticles. Chinese Journal of Pathophysiology. 2014; 572-6.
  17. Qian C, Wang Y, Chen Y, Zeng L, Zhang Q, Shuai X, Huang K. Suppression of pancreatic tumor growth by targeted arsenic delivery with anti-CD44v6 single chain antibody conjugated nanoparticles. Biomaterials. 2013 Aug; 34 (26):6175-84 Epub 2013 May 27
    View PubMed
  18. Chen Y, Lian G, Zhang Q, Zeng L, Qian C, Chen S, Huang K. Overexpression of Bmi-1 induces the malignant transformation of gastric epithelial cells in vitro. Oncol Res. 2013; 21 (1):33-41
    View PubMed
  19. Chen Y, Wang W, Lian G, Qian C, Wang L, Zeng L, Liao C, Liang B, Huang B, Huang K, Shuai X. Development of an MRI-visible nonviral vector for siRNA delivery targeting gastric cancer. Int J Nanomedicine. 2012; 7:359-68 Epub 2012 Jan 31
    View PubMed
  20. Lian G, Deng H, Chen Y, Zeng L, Zhang Q, Qian C, Huang K. Effect of Bmi-1 gene overexpression on proliferation of human gastric mucosal epithelial cell line GES-1. Chinese Journal of Pathophysiology. 2012.
  21. Zhang QB, Chen YT, Lian GD, Qian CC, Chen SJ, Huang KH. A combination of models for end-stage liver disease and cirrhosis-related complications to predict the prognosis of liver cirrhosis. Clinics and research in hepatology and gastroenterology. 2012; 36(6):583-91.
  22. Jin Y, Lu Z, Cao K, Zhu Y, Chen Q, Zhu F, Qian C, Pan J. The antitumor activity of homoharringtonine against human mast cells harboring the KIT D816V mutation. Mol Cancer Ther. 2010 Jan; 9 (1):211-23 Epub 2010 Jan 06
    View PubMed
PST-20574953